Inventor · disambiguated record
Godwin Kwame Kumi
Also filed as: KUMI GODWIN · KUMI GODWIN KWAME
9 granted patents·9 pending applications·44 citations·filing 2013–2024
85Inventor score
Files withBRISTOL MYERS SQUIBB CO7LEXICON PHARMACEUTICALS INC7BI YINGZHI2CELGENE CORP1LEXION PHARMACEUTICALS INC1
Top patents by PatentIndex Score
18 records- 0190US8946415B2Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their useBI YINGZHI·Filed 2013·Granted Feb 3, 2015·17 cites·15 claims
- 0286US9403832B2Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·9 cites·6 claims
- 0386US8969565B2Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their useBI YINGZHI·Filed 2013·Granted Mar 3, 2015·11 cites·5 claims
- 0483US11548870B2Compounds useful as inhibitors of helios proteinBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 10, 2023·1 cites·12 claims
- 0579US9682982B2Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2015·Granted Jun 20, 2017·3 cites·10 claims
- 0675US9725449B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 8, 2017·2 cites·17 claims
- 0773US11166959B2Isofuranone compounds useful as HPK1 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 9, 2021·1 cites·15 claims
- 0873US2024376082A1Pyridinyl substituted oxoisoindoline compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0972US11718601B2Pyridinyl substituted oxoisoindoline compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 8, 2023·0 cites·39 claims
- 1072US2023303527A1Pyridinyl substituted oxoisoindoline compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1166US2024327381A1Compounds and Compositions for Selective Degradation of Engineered ProteinsCELGENE CORP·Filed 2024·Application pending·0 cites
- 1259US2025346574A1Pyridinyl substituted oxoisoindoline compounds for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1350US2015175610A1PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXICON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1448US2017129896A1PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXION PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1547US2017057964A1IMIDAZO[1,2-b]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXICON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1644US2016024093A1IMIDAZO[1,2-b]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXICON PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1743US9862724B2Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2016·Granted Jan 9, 2018·0 cites·13 claims
- 1842US2015183791A1IMIDAZO[1,2-b]PYRIDAZINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USELEXICON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Godwin Kwame Kumi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →